Pradimicin therapy of disseminated Candida tropicalis infection in the mouse

M. I. Restrepo, L. K. Najvar, A. W. Fothergill, J. R. Graybill

Research output: Contribution to journalArticlepeer-review

5 Scopus citations


BMS 181184 (BMS), an analogue of pradimicin, was administered intravenously to neutropenic mice infected with either a fluconazole- susceptible or a fluconazole-resistant clinical isolate of Candida tropicalis. BMS prolonged survival at doses >3 mg kg-1 day-1, and at higher doses reduced tissue counts in mice. BMS was less potent mg for mg than amphotericin B. Combined BMS and amphotericin B were no more effective than either of the individual drugs.

Original languageEnglish (US)
Pages (from-to)181-184
Number of pages4
JournalMedical mycology
Issue number3
StatePublished - Jun 1998


  • BMS
  • Candida tropicalis
  • Fluconazole
  • Mouse model
  • Pradimicin

ASJC Scopus subject areas

  • Infectious Diseases


Dive into the research topics of 'Pradimicin therapy of disseminated Candida tropicalis infection in the mouse'. Together they form a unique fingerprint.

Cite this